Bioguided phytochemical investigation of Sarcococca hookeriana with respect to the cholinesterase enzyme inhibitory assay yielded two new pregnane-type steriodal alkaloids hookerianamide H (1) and hookerianamide I (2), along with three known alkaloids N a -methylepipachysamine D (3), sarcovagine C (4) and dictyophlebine (5). Their structures were determined with the aid of extensive spectroscopic analysis. All compounds showed good inhibitory activities against the enzymes acetylcholinesterase (IC 50 2.9-34.1 m mM) and butyrylcholinesterase (IC 50 0.3-3.6 m mM). These compounds also showed moderate antiplasmodial activity (IC 50 2.4-10.3 m mM) against the Plasmodium falciparum chloroquine resistant W2 strain.
Alzheimer's dementia is characterized by a progressive memory loss that leads to a profound emotional disturbance in later stages. The disease is accompanied by dysfunctions in the system of cholinergic neurotransmission of the central nervous system. The nerve impulse in cholinergic synapses is terminated by the enzyme acetylcholinesterase (AChE, EC 3.1.1.7), which catalyses the hydrolysis of the neurotransmitter acetylcholine. 1) According to the cholinergic hypothesis, the memory impairment in the patients with senile dementia of Alzheimer's type results from a deficiency in cholinergic function in the brain.
2) Reversible inhibition of this enzyme leads to an increase in neurotransmitter concentration within the synaptic cleft, which positively affects Alzheimer's disease (AD) patients. Butyrylcholinesterase (BChE, EC 3.1.1.8) is produced in the liver and enriched in the circulation. The exact physiological role of BChE is still elusive, but it is generally viewed as a backup for the homologous AChE. 3) Hence, the search for the new cholinesterase inhibitors seems to be an important strategy to introduce new drug candidates against Alzheimer's disease and related dementia. Several compounds of the genus Sarcococca are known for their anticholinesterase properties. 4) Sarcococca hookeriana (BAILL.) HOOK. (Buxaceae) is an evergreen shrub, widely distributed from Eastern to Western Nepal, Northern Assam, Southern Tibet and Bhutan. 5) Rural communities in Nepal have been using the root extracts of this plant against gout. 6) Previous studies on the plants from the genus Sarcococca have reported the isolation as well as chemical and microbial transformation of a number of bioactive steroidal alkaloids. [7] [8] [9] [10] [11] [12] Although a number of studies have reported the biological properties of steroidal alkaloids isolated from the family Buxaceae such as cholinesterase inhibtion 7, 8, [11] [12] [13] [14] as well as antibacterial, 15) antitumour 16) and antiulcer 17) activities, no investigation has been reported, to the best of our knowledge, on their antiplasmodial activity. Malaria, mainly caused by the parasite Plasmodium falciparum, remains one of the most important infectious diseases in the world and constitutes a public health problem in more than 90 countries, inhabited by about 40% of the world's population. The World Health Organization (WHO) estimates that there are 300-500 million malaria cases annually, causing 2-3 million deaths, mostly among children under five years old. Africa accounts for over 90% of malaria mortality. 18) Most countries where P. falciparum malaria, the most severe and dangerous form of this disease, is endemic, face significant parasite resistance to frequently used antimalarial drugs, in particular chloroquine and antifolates. For these reasons, new effective and affordable antimalarial drugs are urgently needed. 19) In this regard, research on traditional medicinal plants for their antimalarial constituents is important, to facilitate utilization of available botanical resources and to provide potentially active lead antiplasmodial compounds, perhaps with new mechanism of action.
In continuation of our on-going study to search the bioactive constituents of Buxaceae family, we investigated the plant S. hookeriana and report here the isolation and structure elucidation of two new steroidal alkaloids (1, 2) and the cholinesterase inhibitory as well as antiplasmodial activity of the isolated compounds (1-5).
Results and Discussion
The fractionation and purification by column chromatography of the alkaline dichloromethane and neutral dichloromethane fraction of 80% MeOH-H 2 O extract of the dried plant of S. hookeriana through the bio-assay guided screening based on cholinesterase enzyme-inhibitory assay yielded five steroidal alkaloids 1-5. 22) albeit having a different substituent at the C-3 amino group. In fact, the keto functionality at d 196.2 was placed at C-4 on the basis of its de-shielding effect on conjugated C-2 vinylic proton. 23) This position was further confirmed by the HMBC correlations observed between H-2, H-5 and C-3 NH/C-4 ( Fig. 1) . The position of the formamide group at C-3 was confirmed by the 3 J HMBC correlation observed between the proton at d 8.21/8.30 and C-3. The stereochemistry in compound 1 was largely assigned on biogenetic grounds as all known pregnane-type steroidal alkaloids are being biosynthesized from cholesterol via pregenolone. 8, [11] [12] [13] [14] [15] [16] The assignments were further supported by ROESY experiment and by chemical shift/coupling constant comparison with the reported data. 22) Above mentioned spectroscopic data and comparative literature analysis led us to propose structure 1 to this compound, which was further supported the mass fragmentation pattern Hookerianamide I (2) was obtained as a white amorphous ϩ at m/z 450. The base peak at m/z 58 was due to loss of N-methyl-N-ethyliminium, which is a strong evidence for the attachment of monomethylamino moiety at C-20 of a pregnane-type steroidal skeleton. 11, 13) The study of the 1 H-NMR spectrum (Table 1 ) of compound 2 also supported a pregnane-type steroidal skeleton in compound 2. A singlet at d 2.46 (3H) was assigned to the N amethyl protons attached to C-20, whereas, another singlet at 24) The stereochemistry in compound 2 was also assigned by similar way that explained for compound 1. In ROESY spectrum, C-3 methine proton showed cross peak with C-5 methine proton indicating its a-orientation. On the basis of above observations, compound 2 was 20-(N-methylamino)-3b -(N-methylbenzamido)-5a -pregnane given the trivial name hookerianamide I (2).
In addition to compound 1 and 2, three previously known pregnane-type steroidal alkaloids were also isolated and characterized as N a -methylepipachysamine D (3), sarcovagine C (4) and dictyophlebine (5). 7, 15, 22) Compounds 1-5 were tested in vitro for their inhibitory properties towards AChE and BChE (Table 2 ). All these steroidal alkaloids displayed potent cholinesterase inhibition. As stated in previous reports, 11, 13) the presence of an a,b-unsaturated carbonyl moiety such as in compound 1 increases the inhibitory potential against AChE and BChE. Comparing the activities between compounds 2 and 3 with the C-20 amine substitution pattern being the only difference, compound 2 with N b -monomethyl substituent was found to show higher inhibitory potential towards BChE.
The discovery of potent and safe cholinesterase inhibitors has long been an attractive target for the rational drug design and discovery of mechanism based inhibitors for the treatment of the Alzheimer's disease and related dementias. All the known cholinesterase inhibiting drugs used in the treatment of Alzheimer's disease suffer from several drawbacks such as high toxicity, short duration of biological action, low bioavailability and narrow therapeutic windows. 25) Several natural products have shown promising cholinesterase inhibiting activities both in vivo and in vitro. The alkaloid physostigmine (eserine) obtained from calabar bean Physostigmine venenosum and huperzine-A isolated from Huperzia serrata have exhibited significant cholinesterase inhibitory activities. 26) Hence, the studies on compounds of Sarcococca alkaloids may also be lead candidates in the discovery of clinically useful agents for various nervous system disorders.
Compounds 1-5 were also tested in vitro for their antiplasmodial activity against the W2 strain of P. falciparum, which is resistant to chloroquine and other antimalarials (Table 3 ). All compounds displayed antiplasmodial activity with compound 5 showing the best potency (IC 50 2.4 mM). The contribution of particular functionalities for the activity is not yet known.
These interesting results highlight the antiplasmodial potency of steroidal alkaloids that might be novel lead structures for therapy of malaria or Alzheimer's dementia and related disease.
Experimental
General Experimental Procedure Optical rotations were measured in methanol solution on a Jasco digital polarimeter (model DIP-3600). UV Spectra were recorded in methanol on a Hitachi UV 3200 spectrophotometer. IR Spectra were recorded in CHCl 3 on a Jasco A-302 IR spectropho- C-NMR spectra were referenced to the central peak of CDCl 3 at d 77.0. Coupling constants (J) were measured in Hz. Column chromatography was carried out on silica gel 60 (70-230 and 240-300 mesh sizes, E. Merck). Pre-coated silica gel TLC plates (E. Merck, F 254 ) were used to check the purity of compounds, and Dragendorff's spray reagent was used for the staining of compounds on TLC.
Acetylcholinesterase (Electric-eel EC 3.1.1.7), butyrylcholinesterase (horse-serum E.C 3.1. Extraction and Isolation Air-dried whole plant (31.0 kg) of S. hookeriana was extracted with 80% methanol/water (120 l). The concentrated methanolic aqueous extract (2.8 kg) was dissolved in cold distilled water (12 l) and defatted with petrol ether (30 l) (304.3 g). The aqueous layer was extracted with dichloromethane (30 l) to obtain the neutral fraction (107.8 g). The aqueous fraction was then acidified with acetic acid to pH 3-4 and extracted with dichloromethane (30 l) to obtain the acidic fraction (85.0 g). The aqueous acidic fraction was then made alkaline by adding ammonia solution (pH 9-10) and extracted with dichloromethane (30 l) to obtain the alkaline fraction (24.7 g). The cholinesterase inhibitory activity was determined for the crude MeOH/H 2 O extract (1.0 mg/ml) amounting 81% and 87% inhibition of AChE and BChE, respectively. Similarly, alkaline and neutral dichloromethane fractions (1.0 mg/ml) showed 88% and 97% inhibition for AChE and 85% and 96% inhibition for BChE, respectively. Based on these results, the alkaline fraction was initially selected for bioassay-guided fractionation through a repeated column chromatography, which was adsorbed on 28.0 g of silica gel and eluted with different gradients of petrol ether, acetone and ethanol. Elution with 15% acetone in petrol ether afforded subfraction E (2.1 g), which was adsorbed on 4.0 g of silica gel and chromatographed on a column to afford fifteen sub-fractions E 1 -E 15 . Sub-fractions E 4 -E 8 were found to exhibit significant cholinesterase inhibition activity. Compound 1 (11.5 mg) was obtained by column chromatography of sub-fraction E 5 (70.0 mg) upon elution with petrol ether/acetone/diethylamine (80 : 18 : 2). Similarly, compound 2 (18.3 mg) was obtained after elution of sub-fraction E 7 (90.1 mg) with petrol ether/acetone/diethylamine at 72 : 25 : 3. Similarly, compounds 4 (9.4 mg) and 5 (900.0 mg) were isolated from different sub-fractions of the alkaline fraction and compound 3 (6.7 mg) was isolated from the neutral fraction by silica gel column chromatography.
Hookerianamide H [20- 50 Acetylcholinesterase and butyrylcholinesterase inhibiting activities were measured by a slightly modified spectrophotometric method.
27) Acetylthiocholine iodide and butyrylthiocholine chloride were used as substrates to assay acetylcholinesterase and butyrylcholinesterase, respectively. Test compounds and control (galanthamine) were dissolved in EtOH. 5,5Ј-Dithiobis[2-nitrobenzoic-acid] (DTNB) was used for the measurement of cholinesterase activity. 140 ml of 100 mM sodium phosphate buffer (pH 8.0), 10 ml of DTNB, 20 ml of test compound solution and 20 ml of acetylcholinesterase or butyrylcholinesterase solution were mixed and incubated for 15 min (25°C). The reaction was then initiated by the addition of 10 ml acetylthiocholine or butyrylthiocholine, respectively. The hydrolysis of acetylthiocholine or butyrylthiocholine was monitored at a wavelength of 412 nm (15 min) by the formation of the yellow 5-thio-2-nitrobenzoate anion as the result of the reaction of DTNB with thiocholine, released by the enzymatic hydrolysis of acetylthiocholine and butyrylthiocholine, respectively. All the reactions were performed in triplicate in 96-well micro-plates and monitored in a SpectraMax 340 (Molecular Devices, U.S.A.) spectrometer. The concentrations of test compounds that inhibited the hydrolysis of substrates (acetylthiocholine and butyrylthiocholine) by 50% (IC 50 ) were determined by monitoring the effect of increasing concentrations of these compounds in the assays on the inhibition values. The IC 50 values were then calculated using the EZ-Fit Enzyme Kinetics program (Perrella Scientific Inc., Amherst, U.S.A.).
Evaluation of Antiplasmodial Activity P. falciparum strain W2, which is resistant to chloroquine and other antimalarials 28) was cultured in sealed flasks at 37°C, in a 3% O 2 , 5% CO 2 and 91% N 2 atmosphere in RPMI 1640, 25 mM HEPES, pH 7.4, supplemented with heat inactivated 10% human serum and human erythrocytes to achieve a 2% hematocrit. Parasites were synchronized in the ring stage by serial treatment with 5% sorbitol (Sigma) and studied at 1% parasitemia. 29) Compounds were prepared as 10 mM stock solutions in DMSO, diluted as needed for individual experiments and tested in triplicate. The stock solutions were diluted with supplemented RPMI 1640 medium so as to have at most 0.2% DMSO in the final reaction medium. An equal volume of 1% parasitemia, 4% hematocrit culture was thereafter added and mixed thoroughly. Negative controls contained equal concentration of DMSO. Positive controls contained 1 mM chloroquine phosphate (Sigma). Cultures were incubated at 37°C for 48 h (1 parasite erythrocytic life cycle). Parasites at the ring stage were thereafter fixed by replacing the serum medium by an equal volume of 1% formaldehyde in PBS. Aliquots (50 ml) of each culture were then added to 5 ml round-bottom polystyrene tubes containing 0.5 ml 0.1% Triton X-100 and YOYO nuclear dye (Molecular Probes) in PBS, and parasitemias of treated and control cultures were compared using a Becton-Dickinson FACSort flow cytometer to count nucleated (parasitized) erythrocytes. Data acquisition was performed using CellQuest software. These data were normalized to percent control activity and 50% inhibitory concentrations (IC 50 ) were calculated using Prism 3.0 software (GraphPad) with data fitted by non linear regression to the variable slope sigmoidal dose-response formula, yϭ100/1ϩ10 (log IC 50 Ϫx)H , where H is the hill coefficient or slope factor. 28) 
